The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,601–15,700 of 31,469
Faghihi‐Kashani, S., Bonnet, F., Hafezi‐Nejad, N., Heidari, B., Nargesi, A. A., Sheikhbahaei, S., Ebadi, M., & Esteghamati, A. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.10.001 · Cited by 17
Priya, M., Amutha, A., Pramodkumar, T. A., Ranjani, H., Jebarani, S., Gokulakrishnan, K., Pradeepa, R., Ranjit Unnikrishnan, I., Anjana, R. M., & Mohan, V. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0065 · Cited by 19
Lung function changes in older people with metabolic syndrome and diabetes
Scarlata, S., Fimognari, F. L., Cesari, M., Giua, R., Franco, A., Pasqualetti, P., Pastorelli, R., & Incalzi, R. A. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12026 · Cited by 19
Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis
Arija, S. M., Garnica, I. U., Valdivielso, P., Rioja, J., Jiménez-Núñez, F. G., Irigoyen, M. V., & Fernández‐Nebro, A. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3106-8 · Cited by 22
Angelica acutiloba Root Attenuates Insulin Resistance Induced by High‐Fructose Diet in Rats
Liu, I., Tzeng, T., Liou, S., et al. (2011) · Phytotherapy Research · doi:10.1002/ptr.3403 · Cited by 19
Interleukin-20 circulating levels in obese women: Effect of weight loss
Maiorino, M. I., Schisano, B., Palo, C. D., Vietri, M. T., Cioffi, M., Giugliano, G., Giugliano, D., & Esposito, K. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.03.006 · Cited by 19
Combination Therapy with Metformin and Fenofibrate for Insulin Resistance in Obesity
Xm, L., Li, Y., Zhang, N.-N., Xie, Y.-H., & Shi, Y. Q. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900531 · Cited by 19
Shiwa, M., Yoneda, M., Nakanishi, S., Oki, K., Yamane, K., & Kohno, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120804 · Cited by 19
Atherothrombotic Risk Factors in Subjects with a Family History of Stroke
Lansbury, A. J., Grant, P. J., & Catto, A. J. (2002) · Cerebrovascular Diseases · doi:10.1159/000065677 · Cited by 19
Hypovitaminosis D and insulin resistance in peritoneal dialysis patients
Bindal, M. E., & Taşkapan, H. (2010) · International Urology and Nephrology · doi:10.1007/s11255-010-9813-9 · Cited by 19
Prevalence of diabetes and pre‐diabetes in a cohort of Italian young adults with Williams syndrome
Masserini, B., Bedeschi, M. F., Bianchi, V., Scuvera, G., Beck‐Peccoz, P., Lalatta, F., Selicorni, A., & Orsi, E. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35655 · Cited by 19
Ohbu, K., Adachi, H., Hirai, Y., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12298 · Cited by 19
Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease
Vlek, A. L. M., van der Graaf, Y., Sluman, M. A., Moll, F. L., & Visseren, F. L. J. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2008.12.070 · Cited by 19
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Ohtsuka, N., Kusunoki, T., & Abe, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4879 · Cited by 19
Correlation of Hair Mineral Concentrations with Insulin Resistance in Korean Males
Chung, J., & Yum, K. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9474-x · Cited by 19
Differential association of insulin resistance with cognitive and somatic symptoms of depression
Austin, A. W., Gordon, J. L., Lavoie, K., Arsenault, A., Dasgupta, K., & Bacon, S. (2014) · Diabetic Medicine · doi:10.1111/dme.12465 · Cited by 19
Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
Kuriyama, S., Miwa, Y., Fukushima, H., et al. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.40.116 · Cited by 19
Siahanidou, T., Margeli, A., Kappis, A., Papassotiriou, I., & Mandyla, H. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.002 · Cited by 19
Non-alcoholic fatty liver disease
Bhala, N. B., Usherwood, T., & George, J. (2009) · BMJ · doi:10.1136/bmj.b2474 · Cited by 18
Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
Durazzo, M., Niro, G. A., Premoli, A., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0023-0 · Cited by 19
QT prolongation in patients with Type 2 diabetes and microalbuminuria
Rutter, M. K., Viswanath, S., McComb, J. M., et al. (2002) · Clinical Autonomic Research · doi:10.1007/s10286-002-0036-8 · Cited by 19
Saisho, Y., Hirose, H., Roberts, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073430 · Cited by 19
Man, K., Man, S. S., Shen, J., et al. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32833fad52 · Cited by 19
Rao, M. N., Chau, A., Madden, E., Inslicht, S. S., Talbot, L. S., Richards, A. L., O’Donovan, A., Yack, L. M., Grünfeld, C., & Neylan, T. C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.006 · Cited by 19
Bhat, K. G., & Periasamy, P. (2014) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.137621 · Cited by 19
Miyazaki, T., Hiki, M., Shimada, K., Kume, A., Kiyanagi, T., Sumiyoshi, K., Ohmura, H., & Daida, H. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22152 · Cited by 19
Pereira, R. I., Wang, C. C., Hosokawa, P. W., Dickinson, L. M., Chonchol, M., Krantz, M. J., Steiner, J. F., Bessesen, D. H., Havranek, E. P., & Long, C. S. (2011) · BMC Endocrine Disorders · doi:10.1186/1472-6823-11-13 · Cited by 19
Rungapamestry, V., McMonagle, J., Reynolds, C. M., Rucklidge, G. J., Reid, M., Duncan, G., Ross, K., Horgan, G. W., Toomey, S., MOLONEY, A. P., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201100312 · Cited by 19
Türkmen, K., Tufan, F., Selçuk, E., et al. (2013) · Indian Journal of Nephrology · doi:10.4103/0971-4065.107195 · Cited by 19
Laspa, E., Christen, A., Efstathiadou, Z. A., Johnston, D. G., & Godsland, I. F. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02225.x · Cited by 20
Thomsen, K. L., Sandahl, T. D., Holland‐Fischer, P., Jessen, N., Frystyk, J., Flyvbjerg, A., Grønbæk, H., & Vilstrup, H. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.04.001 · Cited by 20
Bhuiyan, A. R., Chen, W., Srinivasan, S. R., et al. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.218 · Cited by 19
Mu, C., Yang, Y., Luo, Z., & Zhu, W. (2015) · Amino Acids · doi:10.1007/s00726-015-1949-6 · Cited by 19
Silbernagel, G., Renner, W., Grammer, T. B., Hügl, S., Bertram, J., Kleber, M. E., Hoffmann, M. M., Winkelmann, B. R., März, W., & Boehm, B. O. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1194 · Cited by 19
Yoshino, S., Hamasaki, S., Ishida, S., et al. (2012) · Heart and Vessels · doi:10.1007/s00380-011-0228-z · Cited by 19
Tsunoda, F., Koba, S., Hirano, T., Ban, Y., Iso, Y., Suzuki, H., Geshi, E., & Katagiri, T. (2004) · Circulation Journal · doi:10.1253/circj.68.1165 · Cited by 19
Diz-Lois, M. T., García‐Buela, J., Suárez, F., Sangiao‐Alvarellos, S., Vidal, O., & Cordido, F. (2009) · Endocrine · doi:10.1007/s12020-009-9170-6 · Cited by 19
Ochiai, M., Kuroda, T., & Matsuo, T. (2014) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.879288 · Cited by 19
Better cognitive and physical performance is associated with higher blood pressure in centenarians
Szewieczek, J., Duława, J., Gmiński, J., Kurek, A., Legierska, K., Francuz, T., Włodarczyk, I., Janusz-Jenczeń, M., & Hornik, B. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0334-8 · Cited by 19
The susceptibility of three strains of Chinese minipigs to diet-induced type 2 diabetes mellitus
Chen, H., Liu, Y., Li, C., Guo, X.-M., & Huang, L. (2009) · Lab Animal · doi:10.1038/laban1109-355 · Cited by 18
Cabezas, M. C., van Wijk, J. P. H., Elte, J. W. F., & Klop, B. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/394623 · Cited by 20
Romanowska, A., Lebensztejn, D. M., Skiba, E., et al. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2282 · Cited by 19
Karadağ, B., Ozturk, A. O., Şener, N., & Altuntaş, Y. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.12.001 · Cited by 19
Akın, F., Turgut, S., Baştemir, M., Turgut, G., Kurşunluoğlu, R., Karasu, U., & Güçlü, A. (2010) · DNA and Cell Biology · doi:10.1089/dna.2009.0934 · Cited by 19
Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
Okita, K., Iwahashi, H., Kozawa, J., Okauchi, Y., Funahashi, T., Imagawa, A., & Shimomura, I. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12143 · Cited by 19
Aldosterone aggravates glucose intolerance induced by high fructose
Sherajee, S. J., Rafiq, K., Nakano, D., Mori, H., Kobara, H., Hitomi, H., Fujisawa, Y., Kobori, H., Masaki, T., & Nishiyama, A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.051 · Cited by 20
Panidis, D., Τζιόμαλος, Κ., Μacut, D., Kandaraki, E., Tsourdi, E. A., Papadakis, E. P., & Katsikis, I. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.819079 · Cited by 18
Tao, M., Zhang, Z., Zhang, Z., et al. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.13 · Cited by 19
Serum levels of the adipokine Pref-1 in gestational diabetes mellitus
Wurst, U., Ebert, T., Kralisch, S., et al. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.015 · Cited by 19
Lack of GPR40 / FFAR 1 does not induce diabetes even under insulin resistance condition
Matsuda‐Nagasumi, K., Takami‐Esaki, R., Iwachidow, K., Yasuhara, Y., Tanaka, H., Ogi, K., Nakata, M., Yano, T., Hinuma, S., Taketomi, S., et al. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12065 · Cited by 19
β‐Cell Function and Insulin Sensitivity in Adolescents From an OGTT
Sunehag, A. L., Man, C. D., TOFFOLO, G. M., Haymond, M. W., Bier, D. M., & Cobelli, C. (2008) · Obesity · doi:10.1038/oby.2008.496 · Cited by 19
Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patients
Freitas, P., Carvalho, D. M., Santos, A. C., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-348 · Cited by 19
Raz, O., Steinvil, A., Berliner, S. A., Rosenzweig, T., Justo, D., & Shapira, I. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-3 · Cited by 21
Ormsbee, M. J., Rawal, S. R., Baur, D., Kinsey, A. W., Elam, M. L., Spicer, M. T., Fischer, N. T., Madzima, T. A., & Thomas, D. D. (2014) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-11-37 · Cited by 19
de Luis, D. A., Sagrado, M. G., Aller, R., et al. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.006 · Cited by 19
Kim, K.-S., Hong, N.-S., Jacobs, D. R., & Lee, D. (2012) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.2012.45.2.62 · Cited by 19
Association of estrogen receptor alpha gene polymorphisms with metabolic syndrome in Egyptian women.
Ghattas, M., Mehanna, E., Mesbah, N., & Abo-elmatty, D. (2013) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2013.05.014 · Cited by 20
Kong, X., Ma, M., Qin, L., Zhang, Y., Li, X.-Y., Wang, G.-D., Su, Q., & Zhang, D.-Y. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313489061 · Cited by 19
Kong, A. P. S., Choi, K. C., Ko, G. T., Wong, G., Ozaki, R., So, W., Tong, P. C. Y., & Chan, J. C. N. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00410.x · Cited by 19
Ability of Different Measures of Adiposity to Identify High Metabolic Risk in Adolescents
Moreira, C. M. M., Santos, R., Vale, S. M. C. G., Santos, P. C., Abreu, S., Marques, A. I., Soares‐Miranda, L., & Mota, J. A. P. S. (2011) · Journal of Obesity · doi:10.1155/2011/578106 · Cited by 19
Effect of intermittent PTH treatment on plasma glucose in osteoporosis: A randomized trial
D’Amelio, P., Sassi, F., Buondonno, I., et al. (2015) · Bone · doi:10.1016/j.bone.2015.03.018 · Cited by 19
Shahid, A., Lone, K. P., Saeed, S., & Arslan, M. (2008) · HORMONES · doi:10.14310/horm.2002.1212 · Cited by 20
Sham, J. G., Simianu, V. V., Wright, A. S., Stewart, S. D., Alloosh, M., Sturek, M. S., Cummings, D. E., & Flum, D. R. (2014) · Journal of Diabetes Research · doi:10.1155/2014/526972 · Cited by 23
Lipińska, A., Koczaj-Bremer, M., Jankowski, K., Kaźmierczak, A., Ciurzyński, M., Ou-Pokrzewińska, A., Mikocka, E., Lewandowski, Z., Demkow, U. A., & Pruszczyk, P. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-75 · Cited by 19
Ouchfoun, M., Eid, H. M., Musallam, L., Brault, A., Li, S., Vallerand, D., Arnason, J. T., & Haddad, P. S. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0908-z · Cited by 19
Gotoh, H., Gohda, T., Tanimoto, M., Gotoh, Y., Horikoshi, S., & Tomino, Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp290 · Cited by 19
Vaspin Serum Concentration in Patients with Type 2 Diabetes and Carotid Plaque
Li, Z., Ma, C., Li, L., Pan, X., & Chen, L. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000506 · Cited by 19
O’Hartaigh, B. W. J., Thomas, G. N., Silbernagel, G., Bosch, J. A., Pilz, S., Loerbroks, A., Kleber, M. E., Grammer, T. B., Böhm, B. O., & März, W. (2012) · Clinical Endocrinology · doi:10.1111/cen.12024 · Cited by 18
Denis, G. V., & Hamilton, J. A. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000433058.78485.b3 · Cited by 19
Yılmaz, M., Yurtçu, E., Demirci, H., Ergün, M. A., Ersoy, R., Karakoç, A., Yetkin, İ., Çakır, N., Ayvaz, G., & Arslan, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345671 · Cited by 19
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow
Fernandes, C. E., Pompei, L. D. M., Machado, R. B., Ferreira, J. A. D. S., de Melo, N. R., & Peixoto, S. V. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.001 · Cited by 19
Rodríguez‐Morán, M., Guerrero‐Romero, F., & Rascón-Pacheco, R. A. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.08.005 · Cited by 20
Serrano-Ferrer, J., Walther, G., Crendal, E., Vinet, A., Dutheil, F., Naughton, G. A., Lesourd, B., Chapier, R., Courteix, D., & Obert, P. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0116-9 · Cited by 19
Hoppe, C., Kristensen, M., Boiesen, M., Kudsk, J., Michaelsen, K. F., & Mølgaard, C. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509338829 · Cited by 19
Surdacki, A., Kruszelnicka, O., Rakowski, T., Jaźwińska-Kozuba, A., & Dubiel, J. S. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-64 · Cited by 19
Cao, X., Yang, C., Lai, F., Hong, Z., Lin, H.-M., Liu, J., & Li, Y. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12437 · Cited by 19
Protein Intake as a Risk Factor of Overweight/Obesity in 8– to 12–Year-Old Children
Bibiloni, M. D. M., Tur, J. A., Morandi, A., et al. (2015) · Medicine · doi:10.1097/md.0000000000002408 · Cited by 19
Yoshida, K., Kimura, T., Aoki, T., Tsunekawa, K., Araki, O., Shoho, Y., Nara, M., Sumino, H., & Murakami, M. (2016) · Journal of International Medical Research · doi:10.1177/0300060515627561 · Cited by 19
Baktır, A. O., Şarlı, B., Altekin, R. E., Karaman, A., Arınç, H., Sağlam, H., Doğan, Y., Erden, A., & Karaman, H. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5212 · Cited by 19
Kawaguchi, T., Shiba, N. N., Takano, Y., Maeda, T., & Sata, M. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h10-108 · Cited by 20
HYPERTRIGLYCERIDEMIC WAIST PHENOTYPE AND CARDIOMETABOLIC ALTERATIONS IN BRAZILIAN ADULTS.
da Rocha, A. L. C., Pereira, P. F., Pessoa, M. C., Alfenas, R. D. C. G., Segheto, W., da Silva, D. C. G., de Andrade, M. P., & Longo, G. Z. (2015) · PubMed · doi:10.3305/nh.2015.32.3.9305 · Cited by 19
Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults
Pak, K., Lee, S. H., Lee, J. G., Seok, J. W., & Kim, I. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153031 · Cited by 20
Impaired postprandial lipemic response in chronic kidney disease
Saland, J. M., Satlin, L. M., Zalsos-Johnson, J., Cremers, S., & Ginsberg, H. N. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.031 · Cited by 19
Johnston, L., Harris, S. B., Retnakaran, R. R., Zinman, B., Giacca, A., Liu, Z., Bazinet, R. P., & Hanley, A. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4267 · Cited by 19
Miehle, K., Ebert, T., Kralisch, S., Hoffmann, A., Kratzsch, J., Schlögl, H., Stümvoll, M., & Faßhauer, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.04.015 · Cited by 19
Lean and obese dietary phenotypes: differences in energy and substrate metabolism and appetite
Clamp, L. D., Hehir, A. P. J., Lambert, E. V., Beglinger, C., & Goedecke, J. H. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515003402 · Cited by 19
Silva, M. I. B., Cavalieri, V. V. D. S., Lemos, C. C. D. S., Klein, M. R. S. T., & Bregman, R. (2016) · Nutrition · doi:10.1016/j.nut.2016.06.012 · Cited by 18
Hao, M., Yuan, F., Jin, C., Zhou, Z., Cao, Q., Xu, L., Wang, G., Huang, H., Yang, D., Xie, M., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1234 · Cited by 19
Quinn, M. M., Kao, C., Ahmad, A., Lenhart, N. J., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.026 · Cited by 20
Guthrie, G. J., Kulkarni, M., Vlaardingerbroek, H., Stoll, B., Ng, K., Martin, C. R., Belmont, J. W., Hadsell, D. L., Heird, W. C., Newgard, C. B., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069526 · Cited by 21
Deichgræber, P., Witte, D. R., Møller, H. J., Skriver, M. V., Richelsen, B., Jørgensen, M. E., Johansen, N. B., & Sandbæk, A. (2016) · Diabetologia · doi:10.1007/s00125-016-4075-4 · Cited by 19
Hu, X., Pan, X., Ma, X., Luo, Y., Xu, Y., Xiong, Q., Xiao, Y., Bao, Y., & Jia, W. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.147 · Cited by 19
Sandoval-Alzate, H. F., Zapata, Y. A., Clavijo, A. ́. G., et al. (2016) · Scientific Reports · doi:10.1038/srep31661 · Cited by 19
Increased Immune Activation and Exhaustion in HIV-infected Youth
Eckard, A. R., Rosebush, J., Lee, S. T., O’Riordan, M. A., Habib, J. G., Daniels, J. E., Labbato, D. E., Uribe-Leitz, M., Chahroudi, A., & McComsey, G. A. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001326 · Cited by 18
Graus‐Nunes, F., Marinho, T. D. S., Barbosa‐da‐Silva, S., Águila, M. B., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.021 · Cited by 19
Immunometabolic parameters in overweight dogs during weight loss with or without an exercise program
Vitger, A. D., Stallknecht, B. M., Miles, J. E., Hansen, S. L., Vegge, A., & Bjørnvad, C. R. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.10.007 · Cited by 21
Lee, S. W., Kim, H. C., Lee, Y., Song, B., Choi, H., Park, J. H., Rhee, Y., & Kim, C. O. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171761 · Cited by 19
Li, J., Ng, E. H. Y., Stener‐Victorin, E., Hu, Z., Shao, X., Wang, H., Li, M., Lai, M., Xie, C., Su, N., et al. (2017) · Trials · doi:10.1186/s13063-017-1854-2 · Cited by 20
You, M., Kim, H.-J., Rhyu, J., & Kim, H. (2017) · Nutrition Research and Practice · doi:10.4162/nrp.2017.11.3.198 · Cited by 19
A bioenergetics systems evaluation of ketogenic diet liver effects
Hutfles, L. J., Wilkins, H., Koppel, S. J., Weidling, I. W., Selfridge, J. E., Tan, E. P., Thyfault, J. P., Slawson, C. M., Fenton, A. W., Zhu, H., et al. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2017-0068 · Cited by 19
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
